Scientific Sessions 2024  /  You Say You Want a Revolution? Challenges of Deprescribing to Reduce Polypharmacy in Patients With Cardiovascular Disease  /  Panel Discussion
Logo

American Heart Association

  2
  0

Final ID:

Panel Discussion

  • Wehling, Martin  ( University of Heidelberg , Mannheim , Germany )
    • Author Disclosures:
    Martin Wehling: DO have relevant financial relationships ; Royalties/Patent Beneficiary:Springer:Active (exists now) ; Consultant:AcaHealth:Active (exists now) ; Consultant:Optimedis:Active (exists now) ; Speaker:IGAV:Active (exists now) ; Speaker:Berlin Chemie:Past (completed) ; Speaker:Daichii Sankyo:Active (exists now) ; Speaker:NovoNordisk:Active (exists now) ; Speaker:AstraZeneca:Active (exists now) ; Speaker:Novartis:Active (exists now) ; Consultant:Heel:Active (exists now) ; Speaker:BMS:Active (exists now) ; Speaker:Pfizer:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

You Say You Want a Revolution? Challenges of Deprescribing to Reduce Polypharmacy in Patients With Cardiovascular Disease

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
DEBATE (CON): Let it Be: cardiologists should not interfere with non-cardiology treatment plans

Wehling Martin

DEBATE (CON): We can work it out: deprescribing sends the wrong message & should be discouraged

Hernandez Adrian, Fonarow Gregg, Morris Alanna

More abstracts from these authors:
DEBATE (CON): Let it Be: cardiologists should not interfere with non-cardiology treatment plans

Wehling Martin

DEBATE (CON REBUTTAL): Let it Be: cardiologists should not interfere with non-cardiology treatment plans

Wehling Martin

You have to be authorized to contact abstract author. Please, Login
Not Available